Free Disclosure Statement - District Court of Delaware - Delaware

Case 1:07-cv-00654-GI\/IS-LPS Document 2 Filed 10/19/2007 Page 1 of 1
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
————-——----————-—---------· — -~—-——--—----—-·--—---—-—- X
CNS, INC., d/b/a GLAXOSMITI—1I and CREATIVE INTEGRATION & 5
DESIGN, INC.,
Plaintiffs, Civil Action No.
Aso Ltc,
Defendant.
·-—·-----—·——---——---—--—--~-—-—-—-·-—-·—-—--—-—---— -·-X
RULE 7.1 DISCLOSURE STATEMENT OF PLAINTIFFS
Pursuant to Federal Rule of Civil Procedure 7.1, the undersigned counsel for
plaintiffs, CNS, Inc., d/b/a GlaxoSmithKline and Creative Integration & Design, Inc. certifies
that:
1. CNS, Inc., d/b/a GlaxoSmithKline, is a wholly owned subsidiary of
SmithK1ine Beecham Corporation which is a wholly owned subsidiary of GlaxoSmithKline plc.
2. There is no publicly held corporation that owns more than 10% of the
stock in Creative Integration & Design, Inc.
Dated: October 18, 2007 I-
Francis DiGiovanni gi Del. B§No. 3189)
Paul E. Crawford ( Del. Bar No. 493)
CONNOLLY BOVE LODGE & HUTZ LLP
The Nemours Building
Of Counsel: 1007 North Orange Street
P.O. Box 2207
Richard C. Pettus Wilmington, Delaware 19899
Pamela C. White (302) 888-6316
KING & SPALDING LLP [email protected]
1185 Avenue of the Americas —
New York, New York 10036 Attarneysfor Plaintqjfv
(212) 556-2100 CNS Inc., d/b/a GlaxoSmithKline and
Creative Integration & Design, Inc.

Case 1:07-cv-00654-GMS-LPS

Document 2

Filed 10/19/2007

Page 1 of 1